Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Moclobemide and fluoxetine in atypical depression: a double-blind trial.

Lonnqvist J, Sihvo S, Syvälahti E, Kiviruusu O.

J Affect Disord. 1994 Nov;32(3):169-77.

PMID:
7852659
2.

Moclobemide versus fluoxetine for double depression: a randomized double-blind study.

Duarte A, Mikkelsen H, Delini-Stula A.

J Psychiatr Res. 1996 Nov-Dec;30(6):453-8.

PMID:
9023788
3.

A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.

Williams R, Edwards RA, Newburn GM, Mullen R, Menkes DB, Segkar C.

Int Clin Psychopharmacol. 1993 Jan;7(3-4):155-8.

PMID:
8468437
4.

Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.

Lonnqvist J, Sintonen H, Syvälahti E, Appelberg B, Koskinen T, Mannikko T, Mehtonen OP, Naarala M, Sihvo S, Auvinen J, et al.

Acta Psychiatr Scand. 1994 Jun;89(6):363-9.

PMID:
8085464
5.

Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.

Lapierre YD, Joffe R, McKenna K, Bland R, Kennedy S, Ingram P, Reesal R, Rickhi BG, Beauclair L, Chouinard G, Annable L.

J Psychiatry Neurosci. 1997 Mar;22(2):118-26.

6.

Moclobemide versus fluoxetine for a major depressive episode.

Reynaert C, Parent M, Mirel J, Janne P, Haazen L.

Psychopharmacology (Berl). 1995 Mar;118(2):183-7.

PMID:
7617806
7.

Moclobemide and fluoxetine in the prevention of relapses following acute treatment of depression.

Lonnqvist J, Sihvo S, Syvälahti E, Sintonen H, Kiviruusu O, Pitkanen H.

Acta Psychiatr Scand. 1995 Mar;91(3):189-94.

PMID:
7625194
8.

Moclobemide versus fluoxetine in the treatment of inpatients with major depression.

Gattaz WF, Vogel P, Kick H, Kohnen R.

J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):35S-40S.

PMID:
7593728
9.

Moclobemide and fluoxetine in treatment of seasonal affective disorder.

Partonen T, Lönnqvist J.

J Affect Disord. 1996 Nov 25;41(2):93-9.

PMID:
8961036
10.

Moclobemide versus fluoxetine for major depressive episodes.

Geerts S, Bruynooghe F, De Cuyper H, Demeulemeester F, Haazen L.

Clin Neuropharmacol. 1994;17 Suppl 1:S50-7.

PMID:
7954484
11.

Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.

Rimón R, Jääskeläinen J, Kaartinen P, Kalli A, Kilponen E, Koskinen T, Nikkilä H, Pirttiperä V, Seppälä J.

Int Clin Psychopharmacol. 1993 Jan;7(3-4):141-7.

PMID:
8468435
12.
13.

Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.

Orsel Donbak S, Turkçapar MH, Ozturk Kiliç EZ, Demirergi N, Akdemir A, Sirin A, Ozbay MH.

Acta Psychiatr Belg. 1995 May-Jun;95(3):139-51.

PMID:
8525856
14.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
15.
16.

Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.

Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.

Acta Psychiatr Scand Suppl. 1990;360:48-9.

PMID:
2248070
17.

Multicenter double-blind study of moclobemide and maprotiline.

Vaz-Serra A, Figueira ML, Firmino H, Albuquerque AJ, Jara JM, Pestana LC.

Clin Neuropharmacol. 1994;17 Suppl 1:S38-49.

PMID:
7954483
18.

Moclobemide and placebo in mild major depression: a double-blind randomized trial.

Ose E, Holm P.

Psychopharmacology (Berl). 1992;106 Suppl:S114-5.

PMID:
1546122
19.

Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.

Guelfi JD, Payan C, Fermanian J, Pedarriosse AM, Manfredi R.

Br J Psychiatry. 1992 Apr;160:519-24.

PMID:
1571752
20.
Items per page

Supplemental Content

Write to the Help Desk